Phase one trial of Alzheimer's vaccine study demonstrates safety; efficacy studies to follow

Madely Health Headlines Commentary for June 8, 2012

Source:

Alzheimer’s Vaccine Trial a Success

Reference:

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer’s disease: randomised, double-blind, placebo-controlled, first-in-human study. The Lancet Neurology

Bitnami